Peptide Therapy Consultations in Clifton and Tenafly, NJ
Physician consultations with Dr. Jeffrey A. Weiss, MD to review peptide treatment options, the evidence base, regulatory status, risks, and whether a specific peptide may be appropriate for your situation.
Important: Peptides are not a single treatment category with uniform benefits or approval status. Evidence, risks, and regulatory status vary by product and intended use. A consultation does not guarantee a prescription or treatment. Compounded drugs are not FDA-approved; FDA does not verify their safety, effectiveness, or quality before marketing.
A Consultation-Based Review of Peptide Options
Peptides are short chains of amino acids that act as biological messengers, binding to receptors and triggering physiological responses. They have been studied across a range of applications including growth hormone secretion, tissue repair, immune modulation, and metabolic function. The evidence base, regulatory status, and risk profile vary substantially by individual peptide and intended use.
Some peptides have FDA approval for specific indications. Others are used off-label or are available only as compounded preparations. Compounded drugs are not FDA-approved, and the FDA does not evaluate their safety, effectiveness, or quality before they are marketed. The distinction between FDA-approved, off-label, and compounded use is clinically and legally significant.
At Infusion Center of NJ, Dr. Weiss conducts individualized consultations to review your health history, goals, and the specific evidence and regulatory status of any peptide under consideration. A consultation is the appropriate place to discuss what the research supports, what it does not, and what the alternatives are.
What the Consultation Covers
Dr. Weiss reviews the following for each peptide under consideration. This is not a list of guaranteed outcomes or approved indications.
Product-Specific Evidence and Regulatory Review
Evidence, risks, and regulatory status must be assessed for the specific product and intended use. A consultation does not establish that a product is FDA-approved, legally available for compounding, or appropriate for a patient. Dr. Weiss reviews these questions and established alternatives before making any treatment recommendation.
Tissue Repair Research Compounds
BPC-157 and TB-500 have been studied in animal models for tissue repair. Neither has FDA approval for human use. They are not available as FDA-approved drugs and are not established treatments for any human condition. Dr. Weiss reviews the current state of the evidence, the absence of approved human indications, and the risks of compounded preparations.
Unapproved Products and Off-Label Use
Off-label use refers to use of an FDA-approved drug for an unapproved purpose. It does not mean that an unapproved product has FDA approval or can lawfully be prescribed or compounded. Product-specific regulatory status and legal availability require separate verification.
Cognitive Research Compounds
Compounds such as Dihexa and Semax have been studied in preclinical and limited human research for neurological effects. Neither has FDA approval. Evidence in humans is very limited. Dr. Weiss reviews what the research does and does not support and discusses the risks of unapproved compounds.
Metabolic Peptides
AOD-9604 and related compounds have been studied for metabolic effects. AOD-9604 did not receive FDA approval following clinical trials. Dr. Weiss reviews the trial history, current evidence, and alternatives including approved medications.
Investigational Compounds
Epithalon and similar compounds are studied in preclinical research. None have FDA approval. Evidence in humans is very limited. Dr. Weiss reviews what the research does and does not support and discusses the risks of unapproved compounds.
Questions Patients Commonly Bring to Consultation
The following are questions patients often raise when inquiring about peptide therapy. A consultation with Dr. Weiss is required to review the evidence and determine whether any peptide is appropriate for your situation. This is not a list of indications or guaranteed outcomes.
What to Expect with Peptide Therapy
Comprehensive Consultation & Lab Review
Dr. Weiss conducts a thorough intake covering your health history, symptoms, goals, and current medications. He reviews the evidence and regulatory status of any peptide under consideration and discusses alternatives. A consultation does not guarantee a prescription.
Protocol Design & Prescription
If Dr. Weiss determines that a peptide is appropriate for your situation, he designs an individualized protocol and, where applicable, issues a prescription to a licensed compounding pharmacy. He explains the administration method, monitoring plan, and what to watch for.
Injection Training & Ongoing Support
For subcutaneous peptides, our clinical team provides hands-on injection training so you can self-administer safely at home. Follow-up appointments are scheduled to review your response and adjust the protocol as needed.
Common Questions About Peptide Therapy
Schedule a Peptide Therapy Consultation
Schedule a consultation with Dr. Weiss to review your health history, discuss the evidence and regulatory status of peptide options, and determine whether any peptide is appropriate for your care plan.
Peptide therapy requires a clinical consultation and physician prescription. A consultation does not guarantee a prescription or treatment. Available at Clifton and Tenafly, NJ locations.
Found this helpful? Share with someone who might benefit.